Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki : 0.49 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 113.00 | |
25 mg | In stock | $ 198.00 | |
50 mg | In stock | $ 347.00 | |
100 mg | In stock | $ 555.00 | |
500 mg | In stock | $ 1,180.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 79.00 |
Description | GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki : 0.49 μM). |
Targets&IC50 | SARS-CoV PLpro:0.6 μM |
Molecular Weight | 304.39 |
Formula | C20H20N2O |
CAS No. | 1093070-16-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (394.23 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GRL0617 1093070-16-6 Cell Cycle/Checkpoint DNA Damage/DNA Repair Microbiology/Virology Ubiquitination SARS-CoV DUB competitive noncovalent inhibitor Inhibitor Deubiquitinase SARS coronavirus GRL-0617 inhibit GRL 0617 DUBs inhibitor